211 related articles for article (PubMed ID: 29867957)
1. Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?
Ghosh S; Drexler I; Bhatia S; Adler H; Gennery AR; Borkhardt A
Front Immunol; 2018; 9():979. PubMed ID: 29867957
[TBL] [Abstract][Full Text] [Related]
2. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
Bienemann K; Borkhardt A; Klapper W; Oschlies I
Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
[TBL] [Abstract][Full Text] [Related]
3. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.
Youssefian L; Vahidnezhad H; Yousefi M; Saeidian AH; Azizpour A; Touati A; Nikbakht N; Hesari KK; Adib-Sereshki MM; Zeinali S; Mansoori B; Jazayeri A; Karamzadeh R; Fortina P; Jouanguy E; Casanova JL; Uitto J
Clin Infect Dis; 2019 May; 68(11):1938-1941. PubMed ID: 30778533
[TBL] [Abstract][Full Text] [Related]
4. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects.
Ghosh S; Bienemann K; Boztug K; Borkhardt A
J Clin Immunol; 2014 Nov; 34(8):892-9. PubMed ID: 25339095
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
7. Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase.
Alme C; Satwani P; Alobeid B; Bhagat G; Kelly KM
J Pediatr Hematol Oncol; 2015 Oct; 37(7):507-8. PubMed ID: 26056787
[TBL] [Abstract][Full Text] [Related]
8. Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations.
Shadur B; Abuzaitoun O; NaserEddin A; Even-Or E; Zaidman I; Stepensky P
Clin Immunol; 2019 Jan; 198():39-45. PubMed ID: 30572125
[TBL] [Abstract][Full Text] [Related]
9. Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.
McLaughlin LP; Bollard CM; Keller MD
Front Immunol; 2018; 9():556. PubMed ID: 29616044
[TBL] [Abstract][Full Text] [Related]
10. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
Parvaneh N; Filipovich AH; Borkhardt A
Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders.
Shamriz O; Vilk SR; Wolf DG; Ta-Shma A; Averbuch D; Weintraub M; Stepensky P
Clin Immunol; 2014 Apr; 151(2):79-83. PubMed ID: 24584040
[TBL] [Abstract][Full Text] [Related]
12. Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
Heslop HE
Hematology Am Soc Hematol Educ Program; 2005; ():260-6. PubMed ID: 16304390
[TBL] [Abstract][Full Text] [Related]
13. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.
Stepensky P; Weintraub M; Yanir A; Revel-Vilk S; Krux F; Huck K; Linka RM; Shaag A; Elpeleg O; Borkhardt A; Resnick IB
Haematologica; 2011 Mar; 96(3):472-6. PubMed ID: 21109689
[TBL] [Abstract][Full Text] [Related]
14. Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.
Yang X; Nishida N; Zhao X; Kanegane H
Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):462-71. PubMed ID: 26742434
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors.
Eminger LA; Hall LD; Hesterman KS; Heymann WR
J Am Acad Dermatol; 2015 Jan; 72(1):21-34; quiz 35-6. PubMed ID: 25497918
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
17. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
18. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
Worth AJ; Houldcroft CJ; Booth C
Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
20. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]